Top

Published in:

Open Access 01-04-2009 | Basic Neurosciences, Genetics and Immunology - Original Article

Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools

Authors: M. M. M. Verheij, A. R. Cools

Published in: Journal of Neural Transmission | Issue 4/2009

Abstract

Alpha-adrenoceptors in the nucleus accumbens are known to inhibit accumbal dopamine release from reserpine-sensitive pools. The aim of this study was to test our previously reported hypothesis that accumbal noradrenaline that controls the dopamine release from these storage vesicles is derived from alpha-methyl-para-tyrosine-sensitive pools. The sensitivity of accumbal alpha-adrenoceptors to noradrenergic agents depends on the amount of noradrenaline that is available in the synapse. In case the synaptic noradrenaline levels decrease, the conformation of alpha-adrenoceptors changes into a state that makes these receptors more sensitive to its agonists. The effects of alpha-methyl-para-tyrosine, respectively reserpine, on the alpha-adrenoceptor-agonist-induced changes of accumbal dopamine release were investigated. Alpha-methyl-para-tyrosine, but not reserpine, made accumbal postsynaptic alpha-adrenoceptors more sensitive to phenylephrine. These results indicate that noradrenaline that inhibits the release of dopamine from reserpine-sensitive storage vesicles, via stimulation of accumbal postsynaptic alpha-adrenoceptors, is derived from alpha-methyl-para-tyrosine-sensitive pools. The clinical impact of these data is discussed.

Aono Y, Saigusa T, Watanabe S, Iwakami T, Mizoguchi N, Ikeda H, Ishige K, Tomiyama K, Oi Y, Ueda K, Rausch WD, Waddington JL, Ito Y, Koshikawa N, Cools AR (2007) Role of alpha adrenoceptors in the nucleus accumbens in the control of accumbal noradrenaline efflux: a microdialysis study with freely moving rats. J Neural transm 114:1135–1142PubMedCrossRef

Brannan T, Martinez-Tica J, Yahr MD (1991) Effect of yohimbine on brain monoamines: an in vivo study. J Neural Transm Park Dis Dement Sect 3:81–87PubMedCrossRef

Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J (2007) A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry 61:694–699PubMedCrossRef

Cools AR, Tuinstra T (2003) Neurochemical evidence that mesolimbic noradrenaline directs mesolimbic dopamine, implying that noradrenaline, like dopamine, plays a key role in goal-directed and motivational behavior. In: Graybiel AM, Delong MR, Kitai ST (eds) The basal ganglia. VI: Advances in behavioral biology. Plenum, New York, pp 323–334

Cools AR, Verheij MMM (2002) Alpha-adrenoceptors, but not beta-adrenoceptors, regulate the extracellular release of dopamine stored in reserpine-sensitive vesicular pools in the nucleus accumbens. Abstract viewer and itinerary planner 2002 Society for Neuroscience 32nd annual meeting, Orlando. Program No. 736.3.2002

Cools AR, Ellenbroek B, Van den Bos R, Gelissen M (1987) Mesolimbic noradrenaline: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of alpha-noradrenergic agonists. Behav Brain Res 25:49–61PubMedCrossRef

Cools AR, Brachten R, Heeren D, Willemen A, Ellenbroek B (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24:49–69PubMedCrossRef

Cools AR, Van den Bos R, Ploeger G, Ellenbroek BA (1991) Gating function of noradrenaline in the ventral striatum: its role in behavioural responses to environmental and pharmacological challenges. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 141–173

De Leonibus E, Verheij MM, Mele A, Cools A (2006) Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions. Eur J Neurosci 23:1332–1340PubMedCrossRef

Enna SJ, Shore PA (1974) On the nature of the adrenergic neuron extragranular amine binding site. J Neural Transm 35:125–135PubMedCrossRef

Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000) Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23:138–150PubMedCrossRef

Haapalinna A, Leino T, Heinonen E (2003) The alpha-2-adrenoceptor antagonist atipamezole potentiates anti-parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Naunyn Schmiedebergs Arch Pharmacol 368:342–351PubMedCrossRef

Ikeda H, Moribe S, Sato M, Kotani A, Koshikawa N, Cools AR (2007) Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Eur J Pharmacol 554:175–182PubMedCrossRef

Kopin IJ (1964) Storage and metabolism of catecholamines: the role of monoamine oxidase. Pharmacol Rev 16:179–191PubMed

McTavish SF, Callado L, Cowen PJ, Sharp T (1999) Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol 13:379–384PubMedCrossRef

Nurse B, Russell VA, Taljaard JJ (1984) Alpha-2 and beta-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: implications for research into depression. Neurochem Res 9:1231–1238PubMedCrossRef

Nurse B, Russell VA, Taljaard JJ (1985) Effect of chronic desipramine treatment on adrenoceptor modulation of [3H]dopamine release from rat nucleus accumbens slices. Brain Res 334:235–242PubMedCrossRef

Pan JT, Hooth MJ, Lookingland KJ, Moore KE, Marks TA (1993) Comparison of the effects of losulazine and reserpine on central aminergic neurons. Toxicol Appl Pharmacol 123:26–33PubMedCrossRef

Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Elsevier Academic, San Diego

Ruffolo R-RJ, Hieble JP (1994) Alpha-adrenoceptors. Pharmacol Ther 61:1–64PubMedCrossRef

Russell VA, Lamm MC, Taljaard JJ (1988) Effect of ethanol on [3H]dopamine release in rat nucleus accumbens and striatal slices. Neurochem Res 13:487–492PubMedCrossRef

Russell VA, Lamm MC, Taljaard JJ (1993) Lack of interaction between alpha-2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices. Neurochem Res 18:285–289PubMedCrossRef

Saigusa T, Tuinstra T, Koshikawa N, Cools AR (1999) High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine. Neuroscience 88:1153–1163PubMedCrossRef

Schwab ME, Thoenen H (1983) Mechanism of uptake and retrograde axonal transport of noradrenaline in sympathetic neurons in culture: reserpine-resistant large dense-core vesicles as transport vehicles. J Cell Biol 96:1538–1547PubMedCrossRef

Tuinstra T, Cools AR (2000a) High and low responders to novelty: effects of adrenergic agents on the regulation of accumbal dopamine under challenged and non-challenged conditions. Neuroscience 99:55–64PubMedCrossRef

Tuinstra T, Cools AR (2000b) Newly synthesized dopamine in the nucleus accumbens is regulated by beta-adrenergic, but not alpha-adrenergic, receptors. Neuroscience 98:743–747PubMedCrossRef

Van Orden LS, Burke JP, Geyer M, Lodoen FV (1970) Localization of depletion-sensitive and depletion-resistant norepinephrine storage sites in autonomic ganglia. J Pharmacol Exp Ther 174:56–71PubMed

Verheij MM, Cools AR (2007) Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine. J Neurochem 100:810–821PubMedCrossRef

Verheij MM, Cools AR (2008) Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges. Eur J Pharmacol 585:228–244PubMedCrossRef

Verheij MM, De Mulder EL, De Leonibus E, Van Loo KM, Cools AR (2008) Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens. J Neurochem 105:2122–2133CrossRef

Yamazaki T, Kawada T, Akiyama T, Kitagawa H, Takauchi Y, Yahagi N, Sunagawa K (1997) Omega-conotoxin GVIA and desipramine-insensitive norepinephrine efflux from cardiac sympathetic nerve terminal. Brain Res 761:329–332PubMedCrossRef

Zhou J (2004) Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 29:1235–1244PubMedCrossRef

Title: Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools
Authors: M. M. M. Verheij
A. R. Cools
Publication date: 01-04-2009
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 4/2009
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-009-0190-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2009

Expression of GluR6 kainate receptor subunit in granular layer of weaver mouse cerebellum

Serotonin transporter gene polymorphism (5-HTTLPR), environmental conditions, and developing negative emotionality and fear in early childhood

Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release

Globus pallidus internus firing rate modification after motor-imagination in three Parkinson’s disease patients

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

Expression of four housekeeping proteins in elderly patients with schizophrenia